Skip to main content
Journal cover image

Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation.

Publication ,  Journal Article
Madhavan, M; Holmes, DN; Piccini, JP; Ansell, JE; Fonarow, GC; Hylek, EM; Kowey, PR; Mahaffey, KW; Thomas, L; Peterson, ED; Chan, P; Allen, LA ...
Published in: Am Heart J
May 2019

BACKGROUND: The incidence of cognitive impairment and frailty increase with age and may impact both therapy and outcomes in atrial fibrillation (AF). METHODS: We examined the prevalence of clinically recognized cognitive impairment and frailty (as defined by the American Geriatric Society Criteria) in the Outcomes Registry for Better Informed Care in AF (ORBIT AF) and associated adjusted outcomes via multivariable Cox regression. The interaction between cognitive impairment and frailty and oral anticoagulation (OAC) in determining outcomes was examined. RESULTS: Among 9749 patients with AF [median (IQR) age 75 (67-82) y, 57% male], cognitive impairment and frailty was identified in 293 (3.0%) and 575 (5.9%) patients respectively. Frail patients (68 vs 77%, P < .001) and those with cognitive impairment (70 vs 77%, P = .006) were both less likely to receive an OAC. Both cognitive impairment [HR (95% CI) 1.34 (1.05-1.72), P = .0198] and frailty [HR 1.29 (1.08-1.55), P = .0060] were associated with increased risk of death. Cognitive impairment and frailty were not associated with stroke/transient ischemic attack (TIA) or major bleeding. In multivariable analysis, there was no interaction between OAC use and cognitive impairment or frailty in their associations with mortality, major bleeding and a composite end point of stroke, non-central nervous system systemic embolism, TIA, myocardial infarction or cardiovascular death. CONCLUSION: Those with cognitive impairment or frailty in AF had higher predicted risk for stroke and higher observed mortality, yet were less likely to be treated with OAC. Despite this, the benefits of OAC were similar in patients with and without cognitive impairment or frailty.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

May 2019

Volume

211

Start / End Page

77 / 89

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Stroke
  • Risk Factors
  • Male
  • Humans
  • Frailty
  • Follow-Up Studies
  • Female
  • Cognitive Dysfunction
  • Cardiovascular System & Hematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Madhavan, M., Holmes, D. N., Piccini, J. P., Ansell, J. E., Fonarow, G. C., Hylek, E. M., … ORBIT AF Investigators, . (2019). Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation. Am Heart J, 211, 77–89. https://doi.org/10.1016/j.ahj.2019.01.005
Madhavan, Malini, DaJuanicia N. Holmes, Jonathan P. Piccini, Jack E. Ansell, Gregg C. Fonarow, Elaine M. Hylek, Peter R. Kowey, et al. “Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation.Am Heart J 211 (May 2019): 77–89. https://doi.org/10.1016/j.ahj.2019.01.005.
Madhavan M, Holmes DN, Piccini JP, Ansell JE, Fonarow GC, Hylek EM, et al. Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation. Am Heart J. 2019 May;211:77–89.
Madhavan, Malini, et al. “Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation.Am Heart J, vol. 211, May 2019, pp. 77–89. Pubmed, doi:10.1016/j.ahj.2019.01.005.
Madhavan M, Holmes DN, Piccini JP, Ansell JE, Fonarow GC, Hylek EM, Kowey PR, Mahaffey KW, Thomas L, Peterson ED, Chan P, Allen LA, Gersh BJ, ORBIT AF Investigators. Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation. Am Heart J. 2019 May;211:77–89.
Journal cover image

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

May 2019

Volume

211

Start / End Page

77 / 89

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Stroke
  • Risk Factors
  • Male
  • Humans
  • Frailty
  • Follow-Up Studies
  • Female
  • Cognitive Dysfunction
  • Cardiovascular System & Hematology